Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Jingshi Biological Technology is a Chinese biotechnology company specializing in the development and manufacture of molecular biology reagents and kits. The company provides a wide range of products including PCR and qPCR reagents, nucleic acid purification kits, and high-throughput sequencing (NGS) library preparation tools. Jingshi Biological serves academic research institutions, clinical diagnostic laboratories, and industrial partners in the life sciences sector. Their business model focuses on providing high-quality, cost-effective tools for genomic research and molecular diagnostics. The company is headquartered in Beijing and maintains a strong presence in the domestic Chinese research market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jingshi.